These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3508683)

  • 1. Carnitine prevents Reye-like syndrome in atypical carnitine deficiency.
    Matsubasa T; Ohtani Y; Miike T; Kitano A; Endo F; Matsuda I
    Pediatr Neurol; 1986; 2(2):80-4. PubMed ID: 3508683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type II fiber myolysis in a patient with hypocarnitinemia.
    Kimura S; Miyake S
    Brain Dev; 1989; 11(4):263-5. PubMed ID: 2774097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid storage myopathy associated with recurrent Reye syndrome-like attacks, but with a normal carnitine level.
    Matsuishi T; Yuge K; Aramaki S; Yoshino M; Yoshida I; Yamashita F
    Brain Dev; 1988; 10(2):125-9. PubMed ID: 3389475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic carnitine deficiency: benefit of oral carnitine supplements vs. persisting biochemical abnormalities.
    Duran M; de Klerk JB; Wadman SK; Scholte HR; Beekman RP; Jennekens FG
    Eur J Pediatr; 1984 Aug; 142(3):224-8. PubMed ID: 6468448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum and urinary carnitine and organic acids in Reye syndrome and Reye-like syndrome.
    Sugimoto T; Nishida N; Woo M; Takeuchi T; Yasuhara A; Kobayashi Y; Sakane Y
    Brain Dev; 1986; 8(3):257-61. PubMed ID: 3766902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary systemic carnitine deficiency under successful therapy: clinical, biochemical, ultrahistochemical and renal clearance studies.
    von Petrykowski W; Ketelsen UP; Schmidt-Sommerfield E; Penn D; Sawicka E; Struck E; Lehnert W; Haap K; Strassburg HM
    Clin Neuropathol; 1985; 4(2):63-71. PubMed ID: 3995808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary systemic carnitine deficiency presenting as recurrent Reye-like syndrome and dilated cardiomyopathy.
    Hou JW
    Chang Gung Med J; 2002 Dec; 25(12):832-7. PubMed ID: 12635840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic carnitine deficiency--a treatable inherited lipid-storage disease presenting as Reye's syndrome.
    Chapoy PR; Angelini C; Brown WJ; Stiff JE; Shug AL; Cederbaum SD
    N Engl J Med; 1980 Dec; 303(24):1389-94. PubMed ID: 7432384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The differential diagnosis of Reye syndrome: muscle biopsy evaluation.
    Matsuishi T; Yamaguchi Y; Terasawa K; Ohtaki E; Kimura A; Yamashita F
    Brain Dev; 1987; 9(6):610-4. PubMed ID: 3445923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carnitine status in Reye and Reye-like syndromes.
    Matsuda I; Ohtani Y
    Pediatr Neurol; 1986; 2(2):90-4. PubMed ID: 3508684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carnitine palmitoyltransferase 1A deficiency: abnormal muscle biopsy findings in a child presenting with Reye's syndrome.
    Bellusci M; Quijada-Fraile P; Barrio-Carreras D; Martin-Hernandez E; Garcia-Silva M; Merinero B; Perez B; Hernandez-Lain A
    J Inherit Metab Dis; 2017 Sep; 40(5):751-752. PubMed ID: 28466427
    [No Abstract]   [Full Text] [Related]  

  • 12. [An autopsy case of Reye's syndrome associated with deficient muscle carnitine].
    Kobayashi S; Ijima H; Kamoshita S; Kobayashi S; Sugiyama N; Wada Y
    No To Hattatsu; 1984; 16(3):234-9. PubMed ID: 6466499
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum free carnitine in medium chain acyl-CoA dehydrogenase deficiency.
    Bzduch V; Behulova D; Salingova A; Ponec J; Fabriciova K; Kozak L
    Bratisl Lek Listy; 2003; 104(12):405-7. PubMed ID: 15053333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carnitine palmitoyltransferase 2 deficiency: the time-course of blood and urinary acylcarnitine levels during initial L-carnitine supplementation.
    Hori T; Fukao T; Kobayashi H; Teramoto T; Takayanagi M; Hasegawa Y; Yasuno T; Yamaguchi S; Kondo N
    Tohoku J Exp Med; 2010 Jul; 221(3):191-5. PubMed ID: 20543534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zidovudine-induced mitochondrial myopathy is associated with muscle carnitine deficiency and lipid storage.
    Dalakas MC; Leon-Monzon ME; Bernardini I; Gahl WA; Jay CA
    Ann Neurol; 1994 Apr; 35(4):482-7. PubMed ID: 8154877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neonatal presentation of ventricular tachycardia and a Reye-like syndrome episode associated with disturbed mitochondrial energy metabolism.
    Scaglia F; Scheuerle AE; Towbin JA; Armstrong DL; Sweetman L; Wong LJ
    BMC Pediatr; 2002 Dec; 2():12. PubMed ID: 12507404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CPEO and carnitine deficiency overlapping in MELAS syndrome.
    Hsu CC; Chuang YH; Tsai JL; Jong HJ; Shen YY; Huang HL; Chen HL; Lee HC; Pang CY; Wei YH
    Acta Neurol Scand; 1995 Sep; 92(3):252-5. PubMed ID: 7484081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic carnitine deficiency simulating recurrent Reye syndrome.
    Glasgow AM; Eng G; Engel AG
    J Pediatr; 1980 May; 96(5):889-91. PubMed ID: 7365598
    [No Abstract]   [Full Text] [Related]  

  • 19. Reye's syndrome or its metabolic mimics?
    Cannon RA
    Hosp Pract (Off Ed); 1984 Sep; 19(9):134F-134G, 134K, 134O. PubMed ID: 6432814
    [No Abstract]   [Full Text] [Related]  

  • 20. [Alterations of mitochondria in metabolic diseases. Carnitine deficiency, carnitine palmitoyltransferase deficiency and beta oxidation].
    Angelini C
    Acta Neurol (Napoli); 1989 Oct; 11(5):330-4. PubMed ID: 2603779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.